Pages that link to "Q42169034"
Jump to navigation
Jump to search
The following pages link to Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. (Q42169034):
Displaying 38 items.
- Dyslipidaemia of diabetes and the intestine (Q26799589) (← links)
- TANGO1 and Mia2/cTAGE5 (TALI) cooperate to export bulky pre-chylomicrons/VLDLs from the endoplasmic reticulum (Q28118978) (← links)
- Nutritional lipidomics: molecular metabolism, analytics, and diagnostics (Q28390150) (← links)
- Increased intestinal lipid absorption caused by Ire1β deficiency contributes to hyperlipidemia and atherosclerosis in apolipoprotein E-deficient mice. (Q30518782) (← links)
- The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels (Q33804948) (← links)
- Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link? (Q34068407) (← links)
- The relative atherogenicity of VLDL and LDL is dependent on the topographic site (Q34559938) (← links)
- Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice (Q35274124) (← links)
- The Chylomicron: Relationship to Atherosclerosis (Q35295065) (← links)
- Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis (Q36070412) (← links)
- Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome. (Q36149080) (← links)
- Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp rat (Q36522670) (← links)
- Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies (Q36956660) (← links)
- Dyslipidemia in obesity: mechanisms and potential targets (Q36994072) (← links)
- Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report (Q37074292) (← links)
- Postprandial Hyperlipidemia and Remnant Lipoproteins (Q37639159) (← links)
- The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction (Q37666898) (← links)
- Atherosclerosis, diabetes and lipoproteins (Q37770113) (← links)
- New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk (Q37860660) (← links)
- Insights from human congenital disorders of intestinal lipid metabolism (Q38267212) (← links)
- Does Dietary Cholesterol Matter? (Q38980057) (← links)
- High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis (Q39023916) (← links)
- Triacylglycerol-rich lipoproteins derived from healthy donors fed different olive oils modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: the potential role of oleanolic acid. (Q39522952) (← links)
- Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels. (Q40450700) (← links)
- Diabetes and dyslipidemia: characterizing lipoprotein metabolism (Q41283425) (← links)
- Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment (Q42635500) (← links)
- The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects. (Q46545835) (← links)
- Hypertriglyceridemia and atherosclerosis (Q47180199) (← links)
- A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice (Q50320306) (← links)
- Elevated remnant lipoproteins may increase subclinical CVD risk in pre-pubertal children with obesity: a case-control study (Q51347645) (← links)
- Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence (Q51356758) (← links)
- Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes. (Q51381989) (← links)
- Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans (Q51384216) (← links)
- Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. (Q51476370) (← links)
- Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies (Q59797390) (← links)
- The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients (Q83061858) (← links)
- Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity (Q89943751) (← links)
- Dyslipidemia and cardiovascular disease risk among the MASHAD study population (Q90364689) (← links)